HOOKIPA Pharma Inc HOOK:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 11/25/22 EST
1.05quote price arrow up+0.02 (+1.94%)
Volume
200
Close
1.03quote price arrow up+0.03 (+3.00%)
Volume
113,958
52 week range
0.99 - 3.49
Loading...
  • Open1.01
  • Day High1.09
  • Day Low1.01
  • Prev Close1.00
  • 52 Week High3.49
  • 52 Week High Date11/26/21
  • 52 Week Low0.99
  • 52 Week Low Date11/23/22

Key Stats

  • Market Cap56.346M
  • Shares Out54.70M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta0.71
  • YTD % Change-55.79

KEY STATS

  • Open1.01
  • Day High1.09
  • Day Low1.01
  • Prev Close1.00
  • 52 Week High3.49
  • 52 Week High Date11/26/21
  • 52 Week Low0.99
  • 52 Week Low Date11/23/22
  • Market Cap56.346M
  • Shares Out54.70M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta0.71
  • YTD % Change-55.79

RATIOS/PROFITABILITY

  • EPS (TTM)-1.68
  • P/E (TTM)-0.61
  • Fwd P/E (NTM)-0.82
  • EBITDA (TTM)-77.688M
  • ROE (TTM)-66.69%
  • Revenue (TTM)10.316M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-715.77%
  • Debt To Equity (MRQ)3.35%

EVENTS

  • Earnings Date03/20/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On HOOKIPA Pharma Inc

 

Profile

MORE
HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing an immunotherapeutic based on its arenavirus platform, which is designed to target and amplify a T cell and immune response to disease. Its replicating and non-replicating technologies are engineered to induce robust and durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. Its pipeline candidates include HB-200, HB-300, HB-700, HB-101, HB-101...
Jan Van De Winkel Ph.D.
Independent Chairman of the Board
Joern Aldag
Chief Executive Officer, Director
Christine Baker
Chief Operating Officer
Reinhard Kandera
Chief Financial Officer, Director
Roman Necina Ph.D.
Chief Technology Officer
Address
430 East 29Th Street, 14Th Floor
New York, NY
10016-8367
United States

Top Peers

SYMBOLLASTCHG%CHG
EYEN
Eyenovia Inc
1.85-0.04-2.12%
HOWL
Werewolf Therapeutics Inc
1.82-0.01-0.55%
ISR
Isoray Inc
0.3771-0.0219-5.4887%
IMPL
Impel Pharmaceuticals Inc
2.72-0.01-0.37%
SLDB
Solid Biosciences Inc
6.79+0.06+0.89%